Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
01-03 September, 2025
Process DevelopmentProcess Development
Not Confirmed
Not Confirmed
01 September, 2025
Not Confirmed
Not Confirmed
01-03 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
01-03 September, 2025
Process DevelopmentProcess Development
Industry Trade Show
Not Confirmed
01 September, 2025
Industry Trade Show
Not Confirmed
01-03 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/fda-approvals-drop-24-in-h1-2025-gsk-s-uti-med-vertex-s-non-opioid-painkiller-lead-pack-of-first-in-class-meds
26 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/26/3139354/0/en/Genmab-to-Participate-in-a-Fireside-Chat-at-the-Morgan-Stanley-23rd-Annual-Global-Healthcare-Conference.html
26 Aug 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250825239262/en/Genmab-Receives-FDA-Breakthrough-Therapy-Designation-for-Rinatabart-Sesutecan-Rina-S-in-Advanced-Endometrial-Cancer-EC
12 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/12/3132048/0/en/Capital-Increase-in-Genmab-as-a-Result-of-Employee-Warrant-Exercise.html
07 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/07/3129446/0/en/Genmab-Announces-Financial-Results-for-the-First-Half-of-2025.html
07 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/07/3129424/0/en/Genmab-Announces-Phase-3-EPCORE-FL-1-Clinical-Trial-Met-Dual-Primary-Endpoints-in-Patients-with-Relapsed-Refractory-R-R-Follicular-Lymphoma-FL.html
16 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/16/3116237/0/en/Genmab-Announces-Net-Sales-of-DARZALEX-daratumumab-for-Second-Quarter-of-2025.html
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
Genmab is a supplier offers 1 products (APIs, Excipients or Intermediates).
Find a price of HUMAN MONOCLONAL ANTIBODY TO CD4 (ZANOLIMUNAB) bulk offered by Genmab